King Pharmaceuticals to resubmit Remoxy application to FDA FDA approves Alimta as maintenance therapy for advanced lung cancer FDA rejects biotech co.’s non-Hodgkin’s lymphoma treatment Biogen Idec, Acorda Therapeutics to develop, commercialize MS drug BioSante, Cell Genesys to merge Bayer, Celera to develop cancer drugs Merck KGaA launches RebiSmart Takeda completes acquisition of IDM Pharma GSK completes acquisition of Stiefel Active ingredient in eye drug may work as hair loss treatment First Previous 236 237 238
